Passed unanimously without objection! CDC Expert Panel: Pfizer’s vaccination age can be extended to over 16 years old | Anue Juheng-US Stocks

The US Centers for Disease Control and Prevention (CDC) advisory group endorsed the full approval of Pfizer/BioNTech vaccines on Monday (30th), suggesting that the age range for Pfizer vaccines should be extended to over 16 years old.

The 14 members of the CDC Vaccination Advisory Committee unanimously agreed that Pfizer Vaccine can administer vaccines to people over 16 years old. It is expected that CDC Director Rochelle Walensky will accept the endorsement of the expert panel in the near future to make the decision.

The Pfizer/BioNTech vaccine received full approval from the U.S. Food and Drug Administration (FDA) last week and is the first vaccine officially launched in the United States. The Biden administration is working hard to control the spread of the Delta variant virus. The United States hopes to increase the willingness of the people to vaccinate through full approval to curb the spread of the epidemic as soon as possible.

Pfizer/BioNTech passed the FDA’s Emergency Authorization (EUA) in December last year. According to data compiled by the CDC, since Pfizer passed the EUA last year, the company has distributed more than 209 million doses of vaccine.

Many companies, schools, and state and local governments have already formulated vaccination requirements after full authorization. However, CDC data shows that 38% of Americans over the age of 16 still have not been vaccinated, and 20% of those who have not been vaccinated believe that they will be vaccinated only when necessary.

Children aged 12 to 15 are still administering Pfizer vaccines through EUA. Pfizer is collecting more clinical data and preparing to apply for full approval from the FDA. FDA scientist Peter Marks said that as long as the company submits data, the agency will quickly approve the vaccination of children.

In addition, Pfizer/BioNTech also requires regulatory agencies to approve a third dose of the vaccine as a booster dose for all eligible Americans. The main reason is recent indications that the protection of the vaccine has weakened after a period of vaccination. U.S. President Biden said on Friday that regulators are considering an additional third dose of vaccine five months after immunizing people.

The CDC advisory group is expected to further discuss the need for booster doses on Monday. However, the current data needed to assess the use of booster doses by the general population is limited.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.